CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$110.29
−3.98%Forward multiples
Based on analyst estimates
- P/E forward
- 27.64x
- P/E 2026E
- 55.24x
- P/E 2027E
- 26.53x
- P/E 2028E
- 16.00x
- P/S forward
- 8.05x
Trailing multiples
Trailing twelve months
- P/E TTM
- 212.10x
- PEG TTM
- 0.33x
- Price / book
- 16.89x
- Price / sales
- 14.35x
- Price / cash flow
- 108.68x
Enterprise value
- Enterprise value
- $11.6B
- EV / sales
- 13.99x
- EV / EBITDA
- 403.74x
- EV / EBIT
- 1814.74x
- Market cap
- $11.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026